Angiodynamics (ANGO) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to 0.65.
- Angiodynamics' Equity Ratio rose 208.65% to 0.65 in Q4 2025 from the same period last year, while for Nov 2025 it was 0.65, marking a year-over-year increase of 208.65%. This contributed to the annual value of 0.65 for FY2025, which is 92.12% up from last year.
- According to the latest figures from Q4 2025, Angiodynamics' Equity Ratio is 0.65, which was up 208.65% from 0.67 recorded in Q3 2025.
- Over the past 5 years, Angiodynamics' Equity Ratio peaked at 0.87 during Q3 2023, and registered a low of 0.64 during Q4 2024.
- Moreover, its 5-year median value for Equity Ratio was 0.73 (2022), whereas its average is 0.73.
- In the last 5 years, Angiodynamics' Equity Ratio surged by 1665.95% in 2023 and then plummeted by 2269.93% in 2024.
- Quarter analysis of 5 years shows Angiodynamics' Equity Ratio stood at 0.78 in 2021, then decreased by 6.34% to 0.73 in 2022, then rose by 9.88% to 0.8 in 2023, then fell by 20.24% to 0.64 in 2024, then increased by 2.09% to 0.65 in 2025.
- Its Equity Ratio stands at 0.65 for Q4 2025, versus 0.67 for Q3 2025 and 0.65 for Q2 2025.